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A B S T R A C T
Introduction: Breast cancer is the most frequent cancer among women worldwide. Breast cancer incidence in
young women is a health issue of concern, especially in middle-income countries such as Iran. The aim of this
study is to report the breast cancer incidence variations in Golestan province, Iran, over a 10-year period
(2004–2013).
Methods: We analyzed data from the Golestan Population-based Cancer Registry (GPCR), which is a high-quality
cancer registry collecting data on primary cancers based on standard protocols throughout the Golestan pro-
vince. Age-standardized incidence rates (ASRs) and age-specific incidence rates per 100,000 person-years were
calculated. Time trends in ASRs and age-specific rates were evaluated using Joinpoint regressions. The average
annual percentage change (AAPC) with correspondence 95% confidence intervals (95%CIs) were calculated.
Results: A total of 2106 new breast cancer cases were diagnosed during the study period. Most cases occurred in
women living in urban areas: 1449 cases (68%) versus 657 cases (31%) in rural areas. Statistically significant
increasing trends were observed over the 10-year study period amongst women of all ages (AAPC=4.4; 95%CI:
1.2–7.8) as well as amongst women in the age groups 20–29 years (AAPC=10.0; 95%CI: 1.7–19.0) and 30–39
years (AAPC=5.1; 95%CI: 1.4–9.0).
Conclusion: The incidence of breast cancer increased between 2004 and 2013 in Golestan province amongst all
age groups, and in particular amongst women aged 20–39 years. Breast cancer should be considered a high
priority for health policy making in our community.
1. Introduction
Today, cancer is one of the main causes of death worldwide after
cardiovascular disease and stroke [1]. In 2018, breast cancer is esti-
mated to be the most common type of cancer and the main cause of
cancer death amongst women worldwide, with 2,088,849 million new
cases and 626,679 deaths [2].
The incident rate of breast cancer is 46.3 per 100,000 worldwide
[2], and the total number of breast cancer cases is predicted to increase
in the future, reaching 3 million in 2030 [2,3].
Incidence rates are higher in high-income countries: North America,
Western Europe and Oceania, as compared with Africa, South America
and Asia [2]. The breast cancer screening program, as well as a higher
prevalence of risk factors, explain the higher incidence in these
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countries [2,4,5]. According to epidemiological studies, many risk
factors have been proposed for this cancer, including genetic suscept-
ibility, early menarche, lower parity, late age of having first child,
shorter periods of breastfeeding, use of contraceptive and post-
menopausal hormones, overweight and obesity after menopause, lack
of physical activity, and consumption of alcohol [6–9].
Although the incidence of breast cancer in Asian women is lower
than that in Western countries, recent reports suggest increasing trends
(5% per year) in Asian and other developing countries [10–12]. In Iran,
breast cancer is the most common of all cancer types; age standardized
incidence rate is high (ASR=31) (per 100,000 person-years) and is
expected to rise (ASR > 70) by the end of 2030 [2,13]. Comparison
studies between Western and Asian countries illustrate different pat-
terns of breast cancer among female populations, including increasing
trends of breast cancer among young women [12,14]. The peak of
breast cancer in Iran occurred in women aged 40–49 years, in contrast
to that in Western countries but similar to that in Asian countries,
suggesting a high incidence of breast cancer in young Iranian women
[3,15–18]. The recent report from the Golestan Population-based
Cancer Registry (GPCR) showed a rapid increase in age-specific in-
cidence rates of breast cancer among young women in the Golestan
province of Northern Iran [19,20]. While the incidence of breast cancer
in younger women (premenopausal) is lower than in elderly women
(postmenopausal), their related risk factors are known to differ [21].
Thus, breast cancer will be a major health problem with a considerable
burden on healthcare systems in middle-income countries such as Iran
in the near future [15,22,23]. Studying the epidemiology of breast
cancer and its risk factors will help health policy makers to design ef-
fective prevention and early detection programs [24]. Golestan pro-
vince, located on the Asian esophageal cancer belt in Northern Iran, has
been known as a high-risk area for esophageal cancer since the 1970s
[25,26]. It consists of 14 counties, 33 cities and 1051 villages. In this
study, we aimed to report 10-year incidence rates and epidemiological
patterns of breast cancer, especially in young women in the Golestan
province of Iran.
2. Materials and methods
Golestan has a population of about 2 million, representing about
2.3% of the total population of Iran. About half of the Golestan popu-
lation are men, and about half live in urban areas.
This study was conducted using data obtained from the GPCR
during the years 2004–2013. The GPCR collects information on all
cancer cases from all public and private diagnostic and therapeutic
centers, including hospitals, laboratory/pathology and imaging centers,
and some private specialists' offices in Golestan province. In order to
minimize underestimation, the GPCR also collected information from
medical centers and registry centers of neighboring provinces, espe-
cially Tehran, Mazandaran, and Khorasan Razavi. Data were collected
by well-trained cancer registry staff of the GPCR both actively (by
regular visits to all centers to abstract data) and passively (by receiving
regularly cancer-related mortality data from the death registry of the
health department of Golestan University of Medical Sciences
(GOUMS)). Data linkage methods were considered to match death
registry data with the file of registered cancer cases to identify addi-
tional unreported cases, classified as death-certificate-only (DCO) cases.
The GPCR registered only primary cancer cases and secondary tumors
resulting from invasion or metastasis based on the IARC standards [27].
The third edition of the ICD code (ICD-O-III) was used to classify cancer
cases in terms of anatomical site and histology of tumors [28]. As the
quality indices, the proportion of cases with microscopic verification
(MV%) and cases diagnosed by death certificate only (DCO%) were
calculated routinely. The details of the GPCR procedure have been
published recently [20].
CanReg software was used for data entering, quality control and
data analysis [29]. Age-standardized incidence rates (ASRs) (per
100,000 person-years) were calculated based on the World standard
population in year 2000 in 18 5-year age classes (0–4, 5–9…, 85+)
[30]. Information about the population of Golestan was obtained from
the statistics office of the Deputy of Health of GOUMS. The time trends
of the ASR as well as the age-specific incidence rates were calculated.
Average annual percentage change (AAPC) and the corresponding 95%
confidence intervals (95%CIs) were calculated by Joinpoint software
(version 4.6.0.0) [31]; p < 0.05 was considered statistically sig-
nificant. The GPCR protocol was approved by the GOUMS ethics
committee.
3. Results
A total of 2106 new breast cancer cases were diagnosed in Golestan
province during 2004–2013. Most women with a breast cancer diag-
nosis lived in urban areas (1449 cases, 68%) in comparison with rural
areas (657 cases, 31%) (Table 1). The mean (SD) age at diagnosis was
estimated at 46.8 (13.0) years. The GPCR quality factors were calcu-
lated as the proportion of cases with microscopic verification
(MV=76.2) and cases diagnosed by death certificate only
(DCO=2.1%).
The overall ASR of breast cancer (29.1 per 100,000 person-years)
showed a statistically significant increasing trend (AAPC: 4.4; 95%CI:
1.2–7.8; p= 0.013) (Fig. 1) and it was significantly higher in urban
(39.6) than in rural (18.4) areas (p=0.002) during the 10-year study
period (2004–2013). The trends of breast cancer by residence area are
shown in Table 2.
The age-specific incidence rates (per 100,000 person-years) of urban
and rural populations showed that the increasing breast cancer in-
cidence starts in younger age groups (≥20 years) (Fig. 2). The temporal
trends of the age-specific incidence rates based on Joinpoint analysis
illustrated significant increasing trends in breast cancer incidence
among young women, including the age groups 20–29 (AAPC=10.0;
95%CI:1.7–19.0; p= 0.02) and 30–39 years (AAPC=5.1;
95%CI:1.4–9.0; p= 0.01) (Fig. 3, Table 2). Our results also suggested a
significant increase in age-specific rates of breast cancer among older
women, especially those in the age group 60–69 years (AAPC=9.3;
95%CI:1.5–17.8; p= 0.02) (Table 2). The analysis also showed geo-
graphic variations in incidence of breast cancer in Golestan province
with hotspots located in the western area (Fig. 4).
4. Discussion
Several studies indicate that breast cancer incidence rates have been
rising in many countries in Asia, Africa and South America [32]. Our
Table 1
Number, crude rate and age standardized incidence rates (ASR) (per 100,000
person-years) of breast cancer in women; Golestan province, Iran (2004–2013).
Number Crude rate ASR*
Residence Area
Total 2106 24.1 29.1
Urban 1449 34.4 39.6
Rural 657 15.5 18.4
Year
2004 111 14.1 18.3
2005 153 19.1 25.2
2006 183 22.5 27.5
2007 224 27.1 31.8
2008 215 25.6 30.4
2009 213 25.2 29.7
2010 225 26.3 31.0
2011 234 26.7 28.9
2012 263 29.4 33.7
2013 285 31.0 31.7
* ASRs were calculated using Segi’s [30] World standard population.
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study presents an overview of breast cancer incidence rates and trends
among women in Golestan province during the period 2004–2013.
The incidence rate of breast cancer in our population was 29.1 per
100,000 person-years, which was comparable with those reported from
other Asian populations (28.2 per 100,000 person-years) [33]. These
rates are relatively low when compared with the rates reported in po-
pulations of North America and Western Europe [2]. In general, de-
veloped countries have higher breast cancer rates than low- and middle-
income countries, and Asian populations have lower incidence rates
than Western populations [2]. These differences in incidence rates are
likely due to differences in the prevalence of risk factors, such as family
history, reproductive factors and lifestyle factors, and access to and
availability of early detection including screening [33–36].
We found a significant increasing trend in the incidence rates of
breast cancer in our population during the 10-year study period, which
is in concordance with the reported increase in breast cancer incidence
rates in several other countries [33]. Changes in women’s life-
style—including delayed first birth, decreased parity, increasing levels
of overweight and obesity and physical inactivity as the consequences
of urbanization and westernization—may have contributed to in-
creasing the risk of breast cancer in Golestan province and elsewhere
[36]. Recent studies in Iran have concluded that the prevalence of
obesity in Iran has increased, especially in women [37,38], and fertility
rates have declined, likely due, at least in part, to the national family
planning program of recent decades [39].
We also observed statistically significant increasing temporal trends
of breast cancer among young women (20–40 years). While risk factors
for breast cancer occurring in young women are not entirely under-
stood, there are studies suggesting that birth weight, growth rate in
childhood, early-age menarche, and genetic predisposition all affect
risk [40–42]. Comparison between incidence rates of breast cancer
between Asian and Western populations indicate higher rates among
Asian women<40 years of age than amongst Western women in the
same age groups [12,14,43].The peak age for breast cancer diagnosis
among Asian women is in the 4th decade of life (varying by country),
which is similar to our results, whilst in Western countries the mean age
at diagnosis is in the 6th decade of life [14,35]. Several studies, in-
cluding a recent Asian study, indicated that women with breast cancer
diagnosed at younger ages have a genetic predisposition to the disease
[12,44,45]. Therefore, different approaches need to be considered in
order to prevent breast cancer or detect it early in each age group,
especially in young women [12]. Increasing awareness of breast cancer
risk factors, signs and symptoms should be considered as a priority in
breast cancer control planning, especially in our younger female po-
pulation [46,47].
Our results also indicated the significant increasing trends in age-
specific rates of breast cancer in the 60 s age group, which may be due
to several factors such as the use of menopausal hormones, increasing
levels of overweight and obesity, amongst others [48–52]. We found
non-significant decreasing trends in incidence of breast cancer in
women aged>70 years. This may be due to increasing trends in in-
cidence and mortality of cardiovascular diseases in this age group [53].
Fig. 1. Time trending of the age-standardized incidence rates (ASRs) of breast
cancer in women, Golestan province, Iran (2004–2013).
^ Indicates that the average annual percentage change (AAPC) is significantly
different from zero at the level alpha=0.05.
Table 2
The Average Annual Percent Change (AAPC), Confidence Interval (CI) and p-
value of breast cancer by age groups and residence area in women; Golestan
province, Iran (2004–2013).
AAPC Confidence Interval (CI) P-value
Lower CI Upper CI
Age groups (years)
20–29 10.0^ 1.7 19.0 0.02
30–39 5.1^ 1.4 9.0 0.01
40–49 5.0^ 0.2 10.1 0.04
50–59 5.8 −0.3 12.2 0.06
60–69 9.3^ 1.5 17.8 0.02
>=70 −4.4 −9.2 0.6 0.08
Residence area
Urban area 3.8^ 0.3 7.4 0.03
Rural area 4.3^ 0.6 8.1 0.03
^ indicates that the AAPC is significantly different from zero at the
alpha= 0.05 level.
Fig. 2. The age-specific incidence rates (per 100,000 person-years) of breast cancer in women by residence area, Golestan province, Iran (2004–2013).
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As our study was based only on data from the cancer registry, we did
not have information on risk factors other than age and place of re-
sidency (urban or rural); other studies are needed to understand specific
risk factors for breast cancer in this population.
In our study, breast cancer incidence rates were significantly higher
amongst women living in urban areas than amongst those in rural areas,
which is in line with the findings of other studies [54,55]. Reasons for
such differences may include diagnostic bias, as women in urban areas
may have easier access to healthcare facilities [56,57], as well as dif-
ferences in the prevalence of risk factor related to lifestyle, reproductive
factors, and overweight and obesity [35,58].
Women living in western areas of Golestan province had higher
incidence rates than those living in eastern Golestan. These differences
may be due to urbanization, as the city of Gorgan, which is the capital
of the province, is located in the western area. Other possible ex-
planations of the differences in incidence may be related to differences
in population ethnic groups. Turkman and Fars are the two major
ethnics residing in the eastern and western parts of Golestan province,
respectively [59]; these groups may present differences in genetic sus-
ceptibility to breast cancer, as well as differences in other risk factors
[48,60,61], as demonstrated elsewhere. The information about ethni-
city is not available in the GPCR database. Therefore, we could not
perform analysis by ethnicity, which is a limitation of our study. Future
studies should, if possible, include data on ethnicity in this region.
In conclusion, our result showed an increasing trend of breast
cancer incidence in Golestan province during the years 2004–2013 in
all age groups, starting in women aged ≥20. Incidence rates were
higher in the western area of Golestan and in women living in urban
areas. This may be due to the related life-style and genetic risk factors.
In order to prevent and control breast cancer, further studies are needed
to identify risk factors relevant to this region and to design breast
cancer control polices in all age groups, especially in young women.
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Fig. 3. Joinpoint analysis of temporal variation in age-specific rates (per 100,000 person-years) of breast cancer in young women (age groups 20–29 and 30–39
years) in Golestan province, Iran (2004–2013).
^ indicates that the average annual percentage change (AAPC) is significantly different from zero at the level alpha=0.05.
Fig. 4. Age-standardized incidence rates (ASRs) (per 100,000 person-years) of breast cancer in Golestan province, Iran (2004–2013). (A) Urban area; (B) rural area.
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